Last reviewed · How we verify

NCT03786861

Corneal WFG Versus AF Trans PRK in Myopic Patients With High Corneal HOA

Completed NA Last updated 26 December 2018
What this trial tests

NA trial testing corneal WFG group in Myopia in 33 participants. Completed in 31 December 2017.

Timeline
12 January 2017
Primary endpoint
31 December 2017
31 December 2017

Quick facts

Lead sponsorMenoufia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment33
Start date12 January 2017
Primary completion31 December 2017
Estimated completion31 December 2017

Drugs / interventions tested

Conditions studied

Sponsor

Menoufia University

Who can join

Adults 21 to 52, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

compare the efficacy, safety and predictability of corneal wavefront guided (WFG) and aberration free ablation in single-step transepithelial photorefractive keratectomy (TransPRK) in myopic patients with high pre-existing corneal higher order aberrations (HOAs).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Menoufia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03786861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing